Jill B. Brook

Tinnitus in Mast Cell Activation Syndrome: A Prospective Survey of 114 Patients

Z. Kaleem, L. Weinstock, L. Afrin, 2021 .

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series

L. Weinstock, G. Molderings, Jill B. Brook, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment

L. Weinstock, B. Goodman, Jill B. Brook, 2018, BMJ Case Reports.

Mast cell activation symptoms are prevalent in Long-COVID

A. Walters, L. Weinstock, L. Afrin, 2021, International Journal of Infectious Diseases.

Diagnosis of mast cell activation syndrome: a global “consensus-2”

Ilene S Ruhoy, L. Weinstock, M. Wengenroth, 2020, Diagnosis.

Gluten-free diet in postural orthostatic tachycardia syndrome (POTS)

S. Blitshteyn, Jill B. Brook, Kate Zha, 2022, Chronic illness.

Restless legs syndrome is associated with mast cell activation syndrome.

A. Walters, Z. Kaleem, L. Weinstock, 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Restless legs syndrome is associated with long-COVID in women.

A. Walters, L. Weinstock, G. Molderings, 2022, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Health-related quality of life and suicide risk in postural tachycardia syndrome

Cathy L Pederson, Jill B. Brook, 2017, Clinical Autonomic Research.